These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19877531)

  • 1. [Advance on oxidative stress mechanism of arsenic toxicology].
    Li Z; An Y
    Wei Sheng Yan Jiu; 2009 Sep; 38(5):634-6, 640. PubMed ID: 19877531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress as a possible mode of action for arsenic carcinogenesis.
    Kitchin KT; Ahmad S
    Toxicol Lett; 2003 Jan; 137(1-2):3-13. PubMed ID: 12505428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report.
    Clewell HJ; Thomas RS; Gentry PR; Crump KS; Kenyon EM; El-Masri HA; Yager JW
    Toxicol Appl Pharmacol; 2007 Aug; 222(3):388-98. PubMed ID: 17499324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment.
    Kitchin KT; Conolly R
    Chem Res Toxicol; 2010 Feb; 23(2):327-35. PubMed ID: 20035570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?
    Snow ET; Sykora P; Durham TR; Klein CB
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):557-64. PubMed ID: 15996700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and emerging challenges in toxicopathology: carcinogenic threshold of phenobarbital and proof of arsenic carcinogenicity using rat medium-term bioassays for carcinogens.
    Fukushima S; Morimura K; Wanibuchi H; Kinoshita A; Salim EI
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):225-9. PubMed ID: 15993454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence against the nuclear in situ binding of arsenicals--oxidative stress theory of arsenic carcinogenesis.
    Kitchin KT; Wallace K
    Toxicol Appl Pharmacol; 2008 Oct; 232(2):252-7. PubMed ID: 18671993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.
    Kitchin KT
    Toxicol Appl Pharmacol; 2001 May; 172(3):249-61. PubMed ID: 11312654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of active arsenic species produced by metabolic reduction of dimethylarsinic acid in genotoxicity and tumorigenesis.
    Yamanaka K; Kato K; Mizoi M; An Y; Takabayashi F; Nakano M; Hoshino M; Okada S
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):385-93. PubMed ID: 15276418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding arsenic carcinogenicity by the use of animal models.
    Wanibuchi H; Salim EI; Kinoshita A; Shen J; Wei M; Morimura K; Yoshida K; Kuroda K; Endo G; Fukushima S
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):366-76. PubMed ID: 15276416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic-induced oxidative stress and its reversibility.
    Flora SJ
    Free Radic Biol Med; 2011 Jul; 51(2):257-81. PubMed ID: 21554949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenicosis: review of recent advances.
    Pimparkar BD; Bhave A
    J Assoc Physicians India; 2010 Oct; 58():617-24, 629. PubMed ID: 21510113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects.
    Schuhmacher-Wolz U; Dieter HH; Klein D; Schneider K
    Crit Rev Toxicol; 2009; 39(4):271-98. PubMed ID: 19235533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of gene expression profiles in HepG2 cells exposed to arsenic, cadmium, nickel, and three model carcinogens for investigating the mechanisms of metal carcinogenesis.
    Kawata K; Shimazaki R; Okabe S
    Environ Mol Mutagen; 2009 Jan; 50(1):46-59. PubMed ID: 19031421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of oxidative stress with arsenic methylation in chronic arsenic-exposed children and adults.
    Xu Y; Wang Y; Zheng Q; Li X; Li B; Jin Y; Sun X; Sun G
    Toxicol Appl Pharmacol; 2008 Oct; 232(1):142-9. PubMed ID: 18640141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inorganic arsenic-induced intramitochondrial granules in mouse urothelium.
    Suzuki S; Arnold LL; Muirhead D; Lu X; Le XC; Bjork JA; Wallace KB; Ohnishi T; Kakiuchi-Kiyota S; Pennington KL; Cohen SM
    Toxicol Pathol; 2008 Dec; 36(7):999-1005. PubMed ID: 19126794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of plasma alpha-tocopherols on the risk of inorganic arsenic-related urothelial carcinoma.
    Chung CJ; Pu YS; Chen YT; Su CT; Wu CC; Shiue HS; Huang CY; Hsueh YM
    Sci Total Environ; 2011 Feb; 409(6):1039-45. PubMed ID: 21227482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of co-administration of dietary sodium arsenite and an NADPH oxidase inhibitor on the rat bladder epithelium.
    Suzuki S; Arnold LL; Pennington KL; Kakiuchi-Kiyota S; Cohen SM
    Toxicology; 2009 Jun; 261(1-2):41-6. PubMed ID: 19397947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant potential of tea reduces arsenite induced oxidative stress in Swiss albino mice.
    Sinha D; Roy S; Roy M
    Food Chem Toxicol; 2010 Apr; 48(4):1032-9. PubMed ID: 20096321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of arsenic genotoxicity for dose response of carcinogenic effects.
    Rudel R; Slayton TM; Beck BD
    Regul Toxicol Pharmacol; 1996 Apr; 23(2):87-105. PubMed ID: 8661328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.